Literature DB >> 6973587

Immunoglobulin-bearing cells are a target for the antigen-induced inhibition of pokeweed mitogen-stimulated antibody production.

R H Stevens.   

Abstract

In vivo immunization with tetanus toxoid causes the appearance of B cells in the circulation that can produce IgG-antitetanus toxoid antibody in vitro after stimulation by T cells and pokeweed mitogen. Addition of soluble tetanus toxoid to these cultures, however, causes a profound inhibition of the in vitro IgG, but not IgM, antitetanus toxoid antibody production. Treatment of the lymphocytes with 10 microgram of tetanus toxoid for as little as 1 hr at 37 degrees C was sufficient to promote this antigen-specific inhibition. The antigen could be added, however, as late as 3 days after the culture initiation for the inhibition to be observed. Cell separation studies indicated that the inhibitory activity could be found in both the E-rosette positive and E-rosette negative populations. Further studies on the non-E-rosetting cells showed that: 1) inhibition induced in antigen-treated cells could not be transferred to untreated cells; 2) adherent cells were not responsible for the inhibition; 3) treatment of the surface Ig+ cells with antigen was sufficient for the inhibitory effects; and 4) in vivo generated lymphoblastoid cells that produce IgG-antitetanus toxoid antibody in vitro but are surface Ig- were not inhibited by soluble antigen. The results in this study thus indicate that cells in both the E-rosette positive and negative subsets can be responsible for the antigen-induced inhibition of in vitro antibody production observed in the majority of immunized donors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973587

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.

Authors:  V Barnaba; G Valesini; M Levrero; C Zaccari; A Van Dyke; M Falco; A Musca; F Balsano
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

2.  In vitro anti-HBs antibody synthesis from anti-hepatitis B vaccine recipients.

Authors:  V Barnaba; M Levrero; G Ruberti; A van Dyke; A Perrone; A Musca; F Balsano
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

3.  Specific immune responses after booster immunization with tetanus toxoid in man: study of kinetics, family segregation, and linkage to HLA of in vitro lymphocyte proliferative responses and serum-antibody responses.

Authors:  J J Ballet; C Rabian-Herzog; M Lathrop; J F Bourge; M Agrapart; J Drouet; J M Lalouel; J Dausset
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

4.  IgG1 is the predominant subclass of in vivo- and in vitro- produced anti-tetanus toxoid antibodies and also serves as the membrane IgG molecule for delivering inhibitory signals to anti-tetanus toxoid antibody-producing B cells.

Authors:  R Stevens; D Dichek; B Keld; D Heiner
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

5.  Induction of immunoglobulin and antigen-dependent antibody synthesis in human lymphocytes, using supernatants from mitogen-stimulated cultures.

Authors:  M E North; M K Brenner
Journal:  Immunology       Date:  1983-01       Impact factor: 7.397

6.  Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.

Authors:  G M Dusheiko; J H Hoofnagle; W G Cooksley; S P James; E A Jones
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

7.  The interaction of specific T-cell help and non-specific B-cell growth factors in the production of anti-tetanus antibody by human B cells grown in serum-free microcultures.

Authors:  M K Brenner; C A Newton; M E North; C Weyman; J Farrant
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

8.  Human B cell growth factors overcome T cell-mediated inhibition of specific antibody production: a possible mechanism for the exacerbation of autoimmune disease.

Authors:  M K Brenner; M E North
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

9.  Thyroid autoantibody synthesis by cultures of thyroid and peripheral blood lymphocytes. II. Effect of thyroglobulin on thyroglobulin antibody synthesis.

Authors:  S M McLachlan; J Fawcett; M C Atherton; P Thompson; P Baylis; B R Smith
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

10.  T suppressor cells are required for the maintenance of the antigen-induced B-cell unresponsive state in humans.

Authors:  E Benveniste; R H Stevens
Journal:  J Clin Immunol       Date:  1983-04       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.